NCT06669091View on ClinicalTrials.gov

Food-effect Study of Ecopipam Pharmacokinetics

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 22, 2024

Study Completion Date

December 27, 2024

Conditions
Food-effect
Interventions
DRUG

Ecopipam tablet

A single ecopipam 89.6 mg tablet (equivalent to ecopipam HCl 100 mg)

Trial Locations (1)

78209

ICON Early Phase Services, San Antonio

Sponsors
All Listed Sponsors
lead

Emalex Biosciences Inc.

INDUSTRY

NCT06669091 - Food-effect Study of Ecopipam Pharmacokinetics | Biotech Hunter | Biotech Hunter